Skip to search formSkip to main contentSkip to account menu

custirsen

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Medical oncologists who treat men with castration-resistant prostate cancer (CRPC) have seen an abundance of new agents approved… 
Review
2014
Review
2014
  • T. Koltai
  • OncoTargets and therapy
  • 2014
  • Corpus ID: 7322773
Clusterin is a heterodimeric disulfide-linked glycoprotein (449 amino acids) isolated in the rat prostate after castration. It is… 
Review
2013
Review
2013
  • C. Higano
  • OncoTargets and therapy
  • 2013
  • Corpus ID: 6788136
Over the last few years, five agents have demonstrated a survival benefit over a comparator treatment or placebo in the treatment… 
Highly Cited
2012
Highly Cited
2012
Purpose: Clusterin (CLU), an antiapoptotic, stress-associated protein, confers resistance to therapy when overexpressed. This… 
Highly Cited
2011
Highly Cited
2011
Purpose: Clusterin (CLU) is an antiapoptotic, stress-induced protein conferring treatment resistance when overexpressed. This… 
Review
2008
Review
2008
Background: Clusterin is a stress-induced cytoprotective chaperone protein, regulated by HSF1, and functions similarly to a small… 
2008
2008
5002 Background: There is no standard of care when pts with metastatic HRPC manifest disease progression (PD) after 1st-line…